|Mr. Raymond W. Cohen||CEO & Director||871.2k||N/A||1959|
|Mr. Danny L. Dearen||Pres & CFO||636.2k||N/A||1963|
|Mr. Rinda K. Sama||Chief Operating Officer||536.2k||N/A||1979|
|Mr. Guangqiang Jiang Ph.D.||Chief Technology Officer||N/A||N/A||1973|
|Mr. Neil Bhalodkar||VP of Investor Relations||N/A||N/A||N/A|
|Mr. Aaron Pettit||Gen. Counsel & Chief Compliance Officer||N/A||N/A||N/A|
|Mr. John Woock Ph.D.||Chief Marketing Officer||N/A||N/A||1983|
|Mr. Michael V. Williamson||Sr. VP, Gen. & IP Counsel||N/A||N/A||1971|
|Dr. Karen L. Noblett M.D., M.A.S.||Chief Medical Officer||N/A||N/A||1963|
|Mr. Prabodh Mathur||Chief Product Devel. Officer||N/A||N/A||1960|
Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.
Axonics Modulation Technologies, Inc.’s ISS Governance QualityScore as of December 1, 2020 is 8. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 7; Compensation: 8.